Clinical Trials on EGFR 酪氨酸激酶抑制剂加 VEGFR 抑制剂 in Russian Federation
总计1个结果
-
AstraZenecaHutchinson MediPharma (HMP)主动，不招人肾脏肿瘤 | 癌，肾细胞 | 泌尿系肿瘤 | 按部位分类的肿瘤 | 肾脏疾病 | 癌 | 酶抑制剂 | 蛋白激酶抑制剂美国, 意大利, 法国, 大韩民国, 巴西, 俄罗斯联邦, 乌克兰
此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。
赞助者和合作者
- Federal University of Rio Grande do Sul
- Cavis Technologies AB
- TuBerculosis Vaccine Initiative
- Ribomic USA Inc
- Bioservo Technologies AB, Sweden
- Halcygen Pharmaceuticals Limited
- Hartstichting
- Bentong Yu
- Navamindradhiraj University
- Olivier Lambercy
- United Nations Development Programme
- France Cohorte
- Nanjing Brain Hospital, Nanjing Medical University
- ATS Clinical Research
- Repligen Corporation
- George O. Waring IV
- Cambridge Manufacturing Company Limited
- Klang Hospital
- Roche Educational Grant
- Clinical haematology and BMT unit,Saint Louis Hospital,Paris
- 查看完整清单
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Brazil
- Contract Research Organizations in Chile
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Ireland
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Romania
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Thailand
- Contract Research Organizations in Uzbekistan
- CRO list by country